Abstract: Four yeasts (NRRL Y-30213, NRRL Y-30214, NRRL Y-30215, and NRRL Y-30216) and 1 bacterium (NRRL B-30212) have been identified as being superior antagonists capable of suppressing Fusarium head blight (head scab) in cereals, particularly in wheat and barley. Fusarium head blight is primarily caused by the fungus Gibberella zeae (anamorph=Fusarium graminearum).

Abstract: A composition useful for increasing the absorption of glutathione and for synergizing its effects. This composition may take the form of a dietary supplement, dietetic support or of an actual medicine and comprises: (a) propionyl L-carnitine or a pharmacologically acceptable salt thereof; (b) glutathione or a glutathione-containing yeast; (c) a glutathione-free yeast if the component (b) consists of glutathione. The invention is also directed to methods of making this composition as well as to methods of prevention or treatment using it.

Abstract: A method of controlling various insect pests on a plant is disclosed which consists of attracting, augmenting or conserving natural enemies of the insect pests in order to produce a population of the natural enemies sufficient to control the insect pest by applying to the plant an effective amount of a brewer's yeast, S. cervisiae YESTA 20B.

Abstract: A composition for use as a dietary supplement for promoting gastrointestinal health including effective amounts of a dried bacteria, a dried, non-viable yeast and protein. The dried bacteria may be Lactobacillus acidophilus, and may comprise from about 0.1% to about 10% of the total mass of the composition. The yeast may be Brewer's or Baker's yeast, and may comprise from about 2.5% to about 20% of the total mass. The protein may be whey or soy protein concentrates, and may comprise from about 25% to about 98% of the total mass.

Abstract: The present invention pertains to vaccines comprising homogenised inactivated yeast blastospores and homogenised inactivated dermatophyte microconidia or antigenic material of said spores, methods for their production and their use for the prophylaxis and/or treatment of mycoses in mammals, preferably humans. The vaccines according to the present invention are especially useful for the prophylaxis and/or treatment of skin mycosis, preferably Dermatomycosis and/or Candidosis and/or Onychomycosis.

Abstract: Mediating the effects of alcohol consumption by orally administering an active dry yeast containing alcohol dehydrogenase to a person prior to or simultaneously with consumption of an alcohol-containing beverage to oxidize a portion of the alcohol while it is still in the stomach of the person is described.

Abstract: A method of controlling moth and other insect pests in a habitat and attracting, augmenting or conserving natural enemies of the moth or other insect pests, which comprises treating the habitat with yeast.

Abstract: Suspensions, emulsions or dispersions of therapeutically active agents which are water insoluble or water intolerant such as nutritional supplements, herbal products, drugs, bacteria, yeast, vitamins and minerals are prepared as suspensions in edible vegetable oils such as orange, lemon, soybean, cotton seed, peanut, canola corn oil, sunflower, safflower, palm kernel, palm and coconut. The active therapeutic agent may be in crystalline or amorphous form, it may be a liquid as for example an oil such as vitamin E or beta carotene, or a preparation of a comminuted plant structure such as flower, parts, leaf, stem, root or tree bark, or an extract of a dried plant structure, or a freeze dried preparation of a vital bacteria or yeast. The suspension is formed by active mixing of the active agent and oil.

Abstract: The present invention solves the need for non-toxic forms of bioactive chromium which is an essential part of the human diet. This invention provides novel dried-yeast products containing chromium as well as a method of producing the dried yeast products. The method uses organochromium complexes comprised of trivalent chromium, nicotinate, and glycine having high Glucose Tolerance Factor chromium activity. The invention also provides nutritional supplements containing the novel chromium-containing dried-yeast products and methods of administering these products and supplements to increase glucose uptake and insulin binding.

Abstract: A composition and a process for enhancing animal growth by orally administering the animal with the composition are provided. The composition comprises an animal feed and a yeast glucan wherein the animal feed can contain at least one starch-bearing substance such as, for example, grain meal; at least one protein-bearing substance such as, for example, fish meal; a fat-containing substance such as, for example, soybean oil; and the yeast glucan can be obtained from a yeast such as, for example, Saccharomyces cerevisiae.